PwC’s IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027
PwC’s Mike Bellin discusses IPO momentum, AI valuations and the forces shaping the market outlook.
In this Q&A, Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers, discussed the slowdown in IPO momentum, how public investors are evaluating AI companies, biotech’s resurgence and why SPACs are attracting renewed interest. He also outlined what could set the stage for a stronger start to 2027.
Crunchbase News
Source

Generated insight by OnAirToday AI
IPO momentum and investor selectivity shape how companies considering public listings may approach timing and valuation. The discussion also highlights AI, biotech and SPACs as areas influencing the market outlook toward 2027.
Key takeaways
Generated insight by OnAirToday AI
- In this Q&A, Mike Bellin, a partner and U.S.
- IPO services leader at PricewaterhouseCoopers, discussed the slowdown in IPO momentum, how public investors are evaluating AI companies, biotech’s resurgence and why SPACs are attracting renewed interest.
- He also outlined what could set the stage for a stronger start to 2027.
Why it matters: He also outlined what could set the stage for a stronger start to 2027.

Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.